South Korean scientists have developed a method using mussel adhesive protein to connect severed nerve ends without the need to use suture threads.
A joint research team from Pohang University of Science and Technology, Ewha Woman's University, and the Catholic University of Korea Seoul St. Mary’s Hospital announced that it had developed a hydrogel adhesive for medical use based on mussel adhesive protein.
Nerves are one of the more difficult tissues to replicate. As a result, when they are cut, the only option to rejoin them is to carefully sew them together with suture threads.
This approach, however, necessitates a high level of medical expertise and takes a long time. Furthermore, there is a possibility that the secondary injury induced by suture thread penetration will impede nerve cell proliferation.
The researchers aimed to address these issues by transforming mussel adhesive protein into a jelly-like photo-crosslinking hydrogel adhesive.
The protein secreted by mussels to adhere to the moist surfaces of solid rocks is known as mussel adhesive protein.
When not exposed to light, this adhesive lives as a liquid. When exposed to visible light, it rapidly transforms into a hydrogel with sticky properties.
The use of this glue to connect severed nerve segments helps to avoid further injury and minimize immunological inflammation.


NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 



